Meanwhile, other studies also identified that DLGAP5 was detected in various cancers, including hepatocellular carcinoma and ovarian cancer cells [50,56], suggesting its potential role as a fetal oncoprotein. This evidence concerns the gene DLGAP5 and hepatocellular carcinoma.